Research Projects & Grants

For Profit Organization

  • A randomized double-blind, placebo-controlled study of two intravenous dosing regimens of h5G1.1-scFc in patients with acute myocardial infarction undergoing percutaneous transluminal coronary angioplasty reperfusion therapy, Role: Investigator, Procter & Gamble Company, Status: Completed
  • A randomized, double-blind, placebo-controlled study of two intravenous dosing regimens of h5G1.1scFv in patients with acute myocardial infarction undergoing thrombolytic reperfusion therapy, Role: Investigator, Procter & Gamble Company, Status: Completed

Internal

  • An observational study - timing of hospital discharge after antibiotics are changed from intravenous to oral; same day versus next day. A risk benefit analysis., Role: Investigator, Loma Linda University Medical Center, (06/1999 - 05/2000) Status: Completed

Non-Profit Organization

  • Cholesterol and recurrent events (CARE): an inter-continental secondary prevention trial of lowering blood cholesterol after myocardial infarction, Role: Investigator, Bristol-Myers Squibb Foundation, Inc., (05/1997 - 05/1998) Status: Completed